<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04672408</url>
  </required_header>
  <id_info>
    <org_study_id>CER_GVA_2021</org_study_id>
    <nct_id>NCT04672408</nct_id>
  </id_info>
  <brief_title>His Bundle Pacing Versus Right Ventricular Pacing</brief_title>
  <acronym>His-PACE</acronym>
  <official_title>His Bundle Pacing Versus Right Ventricular Pacing: a Randomized Crossover Study (His-PACE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Elise Bakelants</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Carine Stettler</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rene NKoulou</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will randomize cross-over periods of 6 months of right ventricular pacing and His&#xD;
      bundle pacing in patients with baseline left ventricular ejection fraction (LVEF)&gt;40%. The&#xD;
      primary outcome measure is LVEF.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Monocentric, randomized, double-blind comparative crossover clinical study.&#xD;
&#xD;
      Patients with a standard pacing indication with &gt;20% ventricular pacing, with a baseline LVEF&#xD;
      &gt;40%, implanted with a functioning His bundle lead and a backup right ventricular lead, will&#xD;
      be randomized to 6-months periods of right ventricular pacing and of His bundle pacing. The&#xD;
      primary outcome is LVEF assessed by gated Equilibrium Radionuclide Angiography. Secondary&#xD;
      outcomes are diastolic function, New York Heart Association (NYHA) functional class, quality&#xD;
      of life, 6-minute walk test, heart failure hospitalisations and device electrical parameters.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2021</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">February 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Randomized crossover double-blind</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricular ejection fraction</measure>
    <time_frame>6 months</time_frame>
    <description>Assessed by gated Equilibrium Radionuclide Angiography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Left ventricular peak filling rate (EDV/s)</measure>
    <time_frame>6 months</time_frame>
    <description>Assessed by gated Equilibrium Radionuclide Angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NYHA functional class</measure>
    <time_frame>6 months</time_frame>
    <description>Investigator evaluation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6-minute walk test</measure>
    <time_frame>6 months</time_frame>
    <description>Investigator evaluation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life measure by SF-36 questionnaire</measure>
    <time_frame>6 months</time_frame>
    <description>SF-36 questionnaire; 0-100 score (the higher the score, the better the quality of life)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right ventricular ejection fraction</measure>
    <time_frame>6 months</time_frame>
    <description>Assessed by gated Equilibrium Radionuclide Angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital admission for cardiovascular causes</measure>
    <time_frame>6 months</time_frame>
    <description>Number of days of admissions for cardiovascular causes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital admission for cardiovascular causes</measure>
    <time_frame>up to 6 months</time_frame>
    <description>Duration in days of admissions for cardiovascular causes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Pacing-Induced Cardiomyopathy</condition>
  <arm_group>
    <arm_group_label>His bundle pacing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pacing programmed from the His bundle lead</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Right ventricular pacing</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Pacing programmed from the right ventricular lead</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>His bundle pacing</intervention_name>
    <description>Pacing with capture of the His bundle</description>
    <arm_group_label>His bundle pacing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Right ventricular pacing</intervention_name>
    <description>Pacing from the right ventricular lead (septal or apical)</description>
    <arm_group_label>Right ventricular pacing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Baseline LVEF&gt;40%&#xD;
&#xD;
          -  Standard pacing indication with &gt;20% VP&#xD;
&#xD;
          -  Functional His bundle lead with confirmed His capture&#xD;
&#xD;
          -  Functional right ventricular lead with myocardial capture&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable to sign an informed consent form&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haran Burri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Geneva</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Haran Burri, MD</last_name>
    <phone>+41223727200</phone>
    <email>haran.burri@hcuge.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Geneva</name>
      <address>
        <city>Geneva</city>
        <state>GE</state>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 28, 2020</study_first_submitted>
  <study_first_submitted_qc>December 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>December 16, 2020</last_update_submitted>
  <last_update_submitted_qc>December 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Haran Burri, MD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>His bundle pacing</keyword>
  <keyword>Right ventricular pacing</keyword>
  <keyword>Left ventricular systolic function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Yareta data repository</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>At the ocmpletion of the study</ipd_time_frame>
    <ipd_access_criteria>Open access for at least 15 years (as per Swiss law)</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

